Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2012
07/03/2012US8211629 Low pressure sperm cell separation system
07/03/2012US8211439 Albumin fusion proteins comprising insulin polypeptides
07/03/2012US8211426 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
07/03/2012US8211425 Method for treating disseminated cancer
07/03/2012US8211424 Method for treating malignant melanoma
07/03/2012US8211423 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same
07/03/2012US8211421 Mutant having uracil phosphoribosyl transferase activity
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof
07/03/2012CA2463631C Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2446968C Human artificial chromosome containing human antibody .lambda. light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2402593C Monoclonal antibodies to the human ldl receptor, their production and use
07/03/2012CA2397610C In vivo assay for testing the phenotypic stability
07/03/2012CA2336227C Genes involved in tolerance to environmental stress
07/03/2012CA2327387C Cytotoxin-based biological containment
07/03/2012CA2318052C Antibodies against human il-12
07/03/2012CA2296737C Ligand for herpes simplex virus entry mediator and methods of use
06/2012
06/30/2012CA2762823A1 Methods for removing liquid from a porous substrate in a plant somatic embryogenesis
06/28/2012WO2012088434A2 Compositions relating to a phosphoprotein and methods of use
06/28/2012WO2012088412A2 Capture and enrichment of organisms and cells from liquids
06/28/2012WO2012088295A1 A cost-effictive method for expression and purification of recombinant proteins in plants
06/28/2012WO2012088290A2 Tri-variable domain binding proteins and uses thereof
06/28/2012WO2012088272A1 Methods and compositions combining immunotherapy with monocyte activation
06/28/2012WO2012088225A2 Method for identifcation and culture of multipotent mesenchymal stem cells with high proliferation potential
06/28/2012WO2012088071A2 Designer calvin-cycle-channeled and hydrogenotrophic production of butanol and related higher alcohols
06/28/2012WO2012087965A2 Cell culture platform for single cell sorting and enhanced reprogramming of ipscs
06/28/2012WO2012087756A1 Zinc finger nuclease modification of leucine rich repeat kinase 2 (lrrk2) mutant fibroblasts and ipscs
06/28/2012WO2012087730A1 Silicone polymer substrates having improved biological response from hkdcs
06/28/2012WO2012087684A1 A method of diagnosis of fibrosis
06/28/2012WO2012087241A1 Method of purifying exosomes
06/28/2012WO2012086809A1 Accurate and highly sensitive method for measuring activity of human fgf19 and agent for regulating activity of human fgf19
06/28/2012WO2012086756A1 Bioassay method for detecting physiologically active substance
06/28/2012WO2012085348A1 Method of producing human retinal pigmented epithelial cells
06/28/2012WO2012085298A1 Fibrin gel containing sclerocorneal limbus cells and the use thereof in ocular surface bioengineering
06/28/2012WO2012085162A1 Methods for culturing human myeloid leukaemia cells and cells derived therefrom
06/28/2012WO2012084212A1 A method of examining tissue growth and conditioning of cells on a scaffold and a perfusion bioreactor
06/28/2012WO2012083393A2 Recombinant dna vector, method for producing plants that are resistant to environmental stresses, and uses thereof
06/28/2012WO2012061105A3 Homozygous and heterozygous idh1 gene-defective cell lines derived from human colorectal cells
06/28/2012WO2012061075A3 Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
06/28/2012WO2012058522A3 Cancer imaging with therapy: theranostics
06/28/2012WO2012056109A3 Plant derived cell culture material
06/28/2012WO2012054935A3 Formation of hematopoietic progenitor cells from mesenchymal stem cells
06/28/2012WO2012048099A3 Nanoparticle-loaded cells
06/28/2012WO2012033352A3 Equine amniotic fluid derived multipotent stem cells and a production method therefor
06/28/2012WO2012033328A3 Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
06/28/2012WO2012008764A9 Composition for inducing multiple nuclear division of cells
06/28/2012US20120167259 Novel bacillus thuringiensis gene with lepidopteran activity
06/28/2012US20120167258 Temporal Regulation of Gene Expression by MicroRNAs
06/28/2012US20120167257 Method for altering the metabolism of plant
06/28/2012US20120167255 Alteration of embryo/endosperm size during seed development
06/28/2012US20120167254 Disruption of CKX3 and at least one other CKX gene in a plant or plant cell leads to improved traits
06/28/2012US20120167253 Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by rnai
06/28/2012US20120167251 Axmi-031, axmi-039, axmi-040 and axmi-049, a family of novel delta-endotoxin genes and methods for their use
06/28/2012US20120167250 Viral promoter, truncations thereof, and methods of use
06/28/2012US20120167249 Viral promoter, truncations thereof, and methods of use
06/28/2012US20120167248 Regulatory Nucleic Acid Molecules for Enhancing Constitutive Gene Expression in Plants
06/28/2012US20120167246 PLANT NUCLEIC ACIDS ASSOCIATED WITH CELLULAR pH AND USES THEREOF
06/28/2012US20120167245 Genes and uses for plant improvement
06/28/2012US20120167244 Tomato hybrid ps01059664
06/28/2012US20120167243 Pea line ex 08250826
06/28/2012US20120167242 Compositions and methods relating to non-human animals modified to promote production of selected gametes
06/28/2012US20120167241 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish
06/28/2012US20120167240 Compositions and Methods for Modulating PGC-1Alpha to Treat Neurological Diseases and Disorders
06/28/2012US20120167239 Novel ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
06/28/2012US20120167238 Universal peptide tags for transgene polypeptide analysis by mass spectrometry
06/28/2012US20120167237 Animal models and therapeutic molecules
06/28/2012US20120165522 Camptothecin derivatives
06/28/2012US20120165403 Methods of inhibiting the activity of hsp90 and/or aryl hydrocarbon receptor
06/28/2012US20120165400 Gene repair involving in vivo excision of targeting dna
06/28/2012US20120165399 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids
06/28/2012US20120165397 Chemical modification of short small hairpin rnas for inhibition of gene expression
06/28/2012US20120165396 Modulation of exportin 5 expression
06/28/2012US20120165395 Bruton's Tyrosine Kinase As Anti-Cancer Drug Target
06/28/2012US20120165394 Spinal muscular atrophy (sma) treatment via targeting of smn2 splice site inhibitory sequences
06/28/2012US20120165387 General composition framework for ligand-controlled RNA regulatory systems
06/28/2012US20120165365 Compositions and Methods for Treating Cancer
06/28/2012US20120165301 Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
06/28/2012US20120165286 Cyclic nucleotide analogs
06/28/2012US20120165281 Stilbenoid derivatives and their uses
06/28/2012US20120165274 Three-dimensional structures of tall-1 and its cognate receptors and modified proteins and methods related thereto
06/28/2012US20120165267 Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF
06/28/2012US20120165265 Calcium Signaling Modulators Involving STIM and ORAI Proteins
06/28/2012US20120165262 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
06/28/2012US20120165258 Compositions and Methods for Treatment of Thrombosis and for Prolonging Survival of Stored Platelets
06/28/2012US20120165226 Phage display
06/28/2012US20120165204 Genetically Encoded Photomanipulation of Protein and Peptide Activity
06/28/2012US20120164734 Nucleotides encoding stop codons in multiple reading frames and methods of use
06/28/2012US20120164732 Cancer tissue-derived cell mass and a process for preparing same
06/28/2012US20120164731 Method of inducing differentiation from pluripotent stem cells to skeletal muscle progenitor cells
06/28/2012US20120164730 Compositions for silencing the expression of vdac1 and uses thereof
06/28/2012US20120164729 Composition for culturing pluripotent stem cells and use thereof
06/28/2012US20120164728 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/28/2012US20120164727 Productivity augmenting protein factor, novel cell lines and uses thereof
06/28/2012US20120164726 Bivalent, bispecific antibodies
06/28/2012US20120164725 Deepwell plate system with lid
06/28/2012US20120164724 Novel aminotransferase, gene encoding the same, and methods of using them
06/28/2012US20120164705 Metabolic Switch
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 1827